What an mRNA melanoma vaccine may mean for cancer treatment

Science Friday | Sep 3

A new mRNA vaccine for melanoma is making headlines. Moderna and Merck recently announced results from their clinical trial suggesting that this new vaccine, in combination with the cancer drug Keytruda, reduced recurrence rates in patients. The companies have not yet released full data from the trial.

So, how does the vaccine work? And does this mark the beginning of a new era of cancer treatments using mRNA vaccine technology? Ira talks with physician Michael Postow, whose patients were part of the drug trial at Memorial Sloan Kettering Cancer Center.

Guest:

Dr. Michael Postow is chief of the melanoma service at Memorial Sloan Kettering Cancer Center. 

Transcript will be available after the show airs on sciencefriday.com.

Top Stories

9/11 25 Years Later: Remembering the Ordinary Americans Who Died on 9/11

New Jersey columnist Mike Kelly, tells the stories of ordinary Americans, who lost their lives in the 9/11 attacks.
The Brian Lehrer Show |

2026 Fall Schedule Change

WNYC followed up with people whose voices we captured in the aftermath of the September 11th attack to hear their reflections.
WNYC |

Colin Kaepernick, Ten Years After Taking a Knee

In his new memoir, “The Perilous Fight,” the former N.F.L. star recounts the backlash he faced from the league.
The New Yorker Radio Hour |

A Documentary Spotlights the Oldest People in the World

All Of It with Alison Stewart |
YOU ARE ONLINE